In the present study we have measured the concentrations of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in preovulatory follicular fluid (FF) samples obtained from patients undergoing ovulation induction with human menopausal gonadotropin/human chorionic gonadotropin. In 13 of the 24 (54%) FF samples obtained from 20 patients, TNF-α was detected. In contrast, IL-1β was observed in none of the 16 samples assessed. In the samples with detectable levels of TNF-α, the mean concentration was 40.1 pg/ml (range 20-74 pg/ml). In addition, we found an association between the presence of TNF-α in the FF and the serum level of 17β-estradiol (E2) and progesterone (P). The E2 and P levels were significantly lower in patients with detectable levels of TNF-α in FF than in patients with no detectable TNF-α in FF. In summary, the present study shows the presence of TNF-α and the absence IL-1β in hyperstimulated human preovulatory FF. In addition, our results show an association between the presence of TNF-α in FF and low E2 and P levels in serum, suggesting a role for TNF-α in the regulation of human steroidogenesis.
Serum insulin and growth hormone responses to intravenous infusion of arginine were measured in 10 normal control persons and 13 age- and weight-matched nondiabetic psoriatics. The average peak insulin levels, 58.2 μU/ml for normal controls and 47.8 μU/ml for the psoriatics, were recorded at 30 min. The average growth hormone peak values, 20.1 ng/ml for normal controls and 17.8 ng/ml for the psoriatics, were recorded in most cases in 60 min. No significant differences were obtained between the normal controls and psoriatics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.